Tempo Scan Pacific (IDX:TSPC) - Share price, News & Analysis

TSPC fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	3/6
Financial Health	5/6
Dividends	3/6

TSPC Stock Overview

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.

Rewards

PE ratio (7.9x) is below the ID market (18.5x)

Earnings have grown 10.5% per year over the past 5 years

Risk Analysis

Unstable dividend track record

Tempo Scan Pacific Competitors

Tigaraksa Satria

IDX:TGKA

Rp7.6t

Wicaksana Overseas International

IDX:WICO

Rp505.0b

Price History & Performance

Summary of all time highs, changes and price drops for Tempo Scan Pacific
Historical stock prices
Current Share Price	Rp1,445.00
52 Week High	Rp1,790.00
52 Week Low	Rp1,420.00
Beta	0.64
1 Month Change	-1.70%
3 Month Change	-4.93%
1 Year Change	-2.69%
3 Year Change	-9.40%
5 Year Change	-29.51%
Change since IPO	201.04%

Shareholder Returns

	TSPC	ID Pharmaceuticals	ID Market
7D	-1.4%	1.7%	3.1%
1Y	-2.7%	0.5%	18.2%

Return vs Industry: TSPC underperformed the ID Pharmaceuticals industry which returned 0.5% over the past year.

Return vs Market: TSPC underperformed the ID Market which returned 18.2% over the past year.

Price Volatility

Is TSPC's price volatile compared to industry and market?
TSPC volatility
TSPC Average Weekly Movement	1.1%
Pharmaceuticals Industry Average Movement	3.7%
Market Average Movement	6.2%
10% most volatile stocks in ID Market	12.1%
10% least volatile stocks in ID Market	3.0%

Stable Share Price: TSPC is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 1% a week.

Volatility Over Time: TSPC's weekly volatility (1%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1970	4,725	I Made Wijaya	https://www.temposcangroup.com

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products.

Tempo Scan Pacific Fundamentals Summary

How do Tempo Scan Pacific's earnings and revenue compare to its market cap?
TSPC fundamental statistics
Market Cap	Rp6.52t
Earnings (TTM)	Rp823.77b
Revenue (TTM)	Rp11.23t

7.9x

P/E Ratio

0.6x

P/S Ratio

Is TSPC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
TSPC income statement (TTM)
Revenue	Rp11.23t
Cost of Revenue	Rp7.26t
Gross Profit	Rp3.98t
Other Expenses	Rp3.16t
Earnings	Rp823.77b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	182.66
Gross Margin	35.42%
Net Profit Margin	7.33%
Debt/Equity Ratio	11.6%

How did TSPC perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

44%

Payout Ratio

Valuation

Is Tempo Scan Pacific undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

7.91x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: TSPC (IDR1445) is trading above our estimate of fair value (IDR816.99)

Significantly Below Fair Value: TSPC is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: TSPC is good value based on its PE Ratio (7.9x) compared to the ID Pharmaceuticals industry average (20.7x).

PE vs Market: TSPC is good value based on its PE Ratio (7.9x) compared to the ID market (18.5x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TSPC's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: TSPC is good value based on its PB Ratio (1x) compared to the ID Pharmaceuticals industry average (2.5x).

Future Growth

How is Tempo Scan Pacific forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

15.7%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tempo Scan Pacific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Tempo Scan Pacific performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

10.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: TSPC has high quality earnings.

Growing Profit Margin: TSPC's current net profit margins (7.3%) are higher than last year (7.2%).

Past Earnings Growth Analysis

Earnings Trend: TSPC's earnings have grown by 10.5% per year over the past 5 years.

Accelerating Growth: TSPC's earnings growth over the past year (4.6%) is below its 5-year average (10.5% per year).

Earnings vs Industry: TSPC earnings growth over the past year (4.6%) underperformed the Pharmaceuticals industry 11.7%.

Return on Equity

High ROE: TSPC's Return on Equity (12.8%) is considered low.

Financial Health

How is Tempo Scan Pacific's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: TSPC's short term assets (IDR6,239.0B) exceed its short term liabilities (IDR1,895.3B).

Long Term Liabilities: TSPC's short term assets (IDR6,239.0B) exceed its long term liabilities (IDR873.8B).

Debt to Equity History and Analysis

Debt Level: TSPC has more cash than its total debt.

Reducing Debt: TSPC's debt to equity ratio has increased from 3.6% to 11.6% over the past 5 years.

Debt Coverage: TSPC's debt is well covered by operating cash flow (86.7%).

Interest Coverage: TSPC earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Dividend

What is Tempo Scan Pacific current dividend yield, its reliability and sustainability?

Dividend Score

2/6

Dividend Score 2/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

2.77%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: TSPC's dividend (2.77%) is higher than the bottom 25% of dividend payers in the ID market (1.13%).

High Dividend: TSPC's dividend (2.77%) is low compared to the top 25% of dividend payers in the ID market (4.15%).

Stability and Growth of Payments

Stable Dividend: TSPC's dividend payments have been volatile in the past 10 years.

Growing Dividend: TSPC's dividend payments have fallen over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (43.7%), TSPC's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (59.4%), TSPC's dividend payments are covered by cash flows.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.9yrs

Average management tenure

CEO

I Made Wijaya (51 yo)

1.33yrs

Tenure

Mr. I Made Dharma Wijaya had been President Director of PT Tempo Scan Pacific Tbk since 2021 and has been its Director of PT Tempo Scan Pacific Tbk since 2018 and serves as its Managing Director of Sales &...

Leadership Team

Experienced Management: TSPC's management team is considered experienced (4.9 years average tenure).

Board Members

Experienced Board: TSPC's board of directors are considered experienced (5.8 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/21 00:00
End of Day Share Price	2022/05/20 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31